z-logo
Premium
GluN2B‐Selective N ‐Methyl‐ d‐ aspartate (NMDA) Receptor Antagonists Derived from 3‐Benzazepines: Synthesis and Pharmacological Evaluation of Benzo[7]annulen‐7‐amines
Author(s) -
Benner Andre,
Bonifazi Alessandro,
Shirataki Chikako,
Temme Louisa,
Schepmann Dirk,
Quaglia Wilma,
Shoji Osami,
Watanabe Yoshihito,
Daniliuc Constantin,
Wünsch Bernhard
Publication year - 2014
Publication title -
chemmedchem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.817
H-Index - 100
eISSN - 1860-7187
pISSN - 1860-7179
DOI - 10.1002/cmdc.201300547
Subject(s) - chemistry , stereochemistry , phencyclidine , nmda receptor , moiety , ifenprodil , receptor , biochemistry
Given their high neuroprotective potential, ligands that block GluN2B‐containing N ‐methyl‐ D ‐aspartate (NMDA) receptors by interacting with the ifenprodil binding site located on the GluN2B subunit are of great interest for the treatment of various neuronal disorders. In this study, a novel class of GluN2B‐selective NMDA receptor antagonists with the benzo[7]annulene scaffold was prepared and pharmacologically evaluated. The key intermediate, N ‐(2‐ m ethoxy‐5‐oxo‐6,7,8,9‐tetrahydro‐5 H ‐benzo[7]annulen‐7‐yl)acetamide ( 11 ), was obtained by cyclization of 3‐acetamido‐5‐(3‐methoxyphenyl)pentanoic acid ( 10 b ). The final reaction steps comprise hydrolysis of the amide, reduction of the ketone, and reductive alkylation, leading to cis ‐ and trans ‐configured 7‐(ω‐phenylalkylamino)benzo[7]annulen‐5‐ols. High GluN2B affinity was observed with cis ‐configured γ‐amino alcohols substituted with a 3‐phenylpropyl moiety at the amino group. Removal of the benzylic hydroxy moiety led to the most potent GluN2B antagonists of this series: 2‐methoxy‐ N ‐(3‐phenylpropyl)‐6,7,8,9‐tetrahydro‐5 H ‐benzo[7]annulen‐7‐amine ( 20 a , K i =10 n M ) and 2‐methoxy‐ N ‐methyl‐ N ‐(3‐phenylpropyl)‐6,7,8,9‐tetrahydro‐5 H ‐benzo[7]annulen‐7‐amine ( 23 a , K i =7.9 n M ). The selectivity over related receptors (phencyclidine binding site of the NMDA receptor, σ 1 and σ 2 receptors) was recorded. In a functional assay measuring the cytoprotective activity of the benzo[7]annulenamines, all tested compounds showed potent NMDA receptor antagonistic activity. Cytotoxicity induced via GluN2A subunit‐containing NMDA receptors was not inhibited by the new ligands.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here